Vietnam To Review Approval Process For Merck and GSK Cancer Vaccines After Reports Of Unethical Lobbying, Efficacy Concerns
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Vietnam's Ministry of Health has decided to review the approval process of two cervical cancer vaccines -Gardasil of Merck Sharp & Dohme and GlaxoSmithKline's Cervarix, the ministry announced Dec. 17
You may also be interested in...
Japan's MHLW Says HPV DNA Testing “Unnecessary” In Cervical Cancer Screening Guidelines
Japan's Ministry of Health, Labor and Welfare's research team Dec. 8 issued a finding on the use of human papillomavirus DNA testing for cervical cancer screening. According to the report, the team concluded that it was insufficient to prove that HPV testing lowered cervical cancer death rates, and the team recommended that testing not be included in the regular medical checklist
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).